Clinical trials
Recruiting Squamous Cell Carcinoma of Head and Neck trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Bicara Therapeutics | 1 |
| Cancer Research UK | 1 |
| Corbus Pharmaceuticals Inc. | 1 |
| Eli Lilly and Company | 1 |
| Epkin | 1 |
| Exelixis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 25 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Stomach Neoplasms | 8 |
| Colorectal Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
| Esophageal Neoplasms | 5 |
| Esophageal Squamous Cell Carcinoma | 5 |
| Neoplasm Metastasis | 5 |
| Ovarian Neoplasms | 4 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.